Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/43246
Title: Search for Specific Biomarkers of IFNb Bioactivity in Patients with Multiple Sclerosis
Author: Malhotra, Sunny
Bustamante, Marta F.
Perez Miralles, Francisco
Rio, Jordi
Ruiz de Villa, Mari Carmen
Vegas, Esteban
Nonell, Lara
Deisenhammer, Florian
Fissolo, Nicolás.
Nurtdinov, Ramil N.
Montalbán Gairín, Xavier
Comabella López, Manuel
Keywords: Esclerosi múltiple
Marcadors bioquímics
Multiple sclerosis
Biochemical markers
Issue Date: 23-Aug-2011
Publisher: Public Library of Science (PLoS)
Abstract: Myxovirus A (MxA), a protein encoded by the MX1 gene with antiviral activity, has proven to be a sensitive measure of IFNβ bioactivity in multiple sclerosis (MS). However, the use of MxA as a biomarker of IFNβ bioactivity has been criticized for the lack of evidence of its role on disease pathogenesis and the clinical response to IFNβ. Here, we aimed to identify specific biomarkers of IFNβ bioactivity in order to compare their gene expression induction by type I IFNs with the MxA, and to investigate their potential role in MS pathogenesis. Gene expression microarrays were performed in PBMC from MS patients who developed neutralizing antibodies (NAB) to IFNβ at 12 and/or 24 months of treatment and patients who remained NAB negative. Nine genes followed patterns in gene expression over time similar to the MX1, which was considered the gold standard gene, and were selected for further experiments: IFI6, IFI27, IFI44L, IFIT1, HERC5, LY6E, RSAD2, SIGLEC1, and USP18. In vitro experiments in PBMC from healthy controls revealed specific induction of selected biomarkers by IFNβ but not IFNγ, and several markers, in particular USP18 and HERC5, were shown to be significantly induced at lower IFNβ concentrations and more selective than the MX1 as biomarkers of IFNβ bioactivity. In addition, USP18 expression was deficient in MS patients compared with healthy controls (p = 0.0004). We propose specific biomarkers that may be considered in addition to the MxA to evaluate IFNβ bioactivity, and to further explore their implication in MS pathogenesis.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0023634
It is part of: PLoS One, 2011, vol. 6, num. 8, p. e23634
Related resource: http://dx.doi.org/10.1371/journal.pone.0023634
URI: http://hdl.handle.net/2445/43246
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
609649.pdf547.73 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons